vs
Hillman Solutions Corp.（HLMN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Hillman Solutions Corp.的1.7倍（$622.0M vs $370.1M），Royalty Pharma plc净利率更高（34.4% vs -1.3%，领先35.7%），Royalty Pharma plc同比增速更快（4.8% vs 3.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -1.2%）
Hillman Solutions是一家美国企业，核心业务涵盖五金产品制造、分销以及面向消费者的定制加工服务，为市场提供多元化的五金相关解决方案，服务覆盖产业链多个环节。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HLMN vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.7倍
$370.1M
营收增速更快
RPRX
高出1.8%
3.0%
净利率更高
RPRX
高出35.7%
-1.3%
两年增速更快
RPRX
近两年复合增速
-1.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $370.1M | $622.0M |
| 净利润 | $-4.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 62.4% |
| 净利率 | -1.3% | 34.4% |
| 营收同比 | 3.0% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $-0.02 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HLMNRPRX
| Q1 26 | $370.1M | — | ||
| Q4 25 | $365.1M | $622.0M | ||
| Q3 25 | $424.9M | $609.3M | ||
| Q2 25 | $402.8M | $578.7M | ||
| Q1 25 | $359.3M | $568.2M | ||
| Q4 24 | $349.6M | $593.6M | ||
| Q3 24 | $393.3M | $564.7M | ||
| Q2 24 | $379.4M | $537.3M |
净利润HLMNRPRX
| Q1 26 | $-4.7M | — | ||
| Q4 25 | $1.6M | $214.2M | ||
| Q3 25 | $23.2M | $288.2M | ||
| Q2 25 | $15.8M | $30.2M | ||
| Q1 25 | $-317.0K | $238.3M | ||
| Q4 24 | $-1.2M | $208.2M | ||
| Q3 24 | $7.4M | $544.0M | ||
| Q2 24 | $12.5M | $102.0M |
营业利润率HLMNRPRX
| Q1 26 | 1.9% | — | ||
| Q4 25 | 4.6% | 62.4% | ||
| Q3 25 | 10.8% | 70.1% | ||
| Q2 25 | 9.0% | 36.3% | ||
| Q1 25 | 4.2% | 94.0% | ||
| Q4 24 | 4.0% | 60.9% | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 8.3% | 50.2% |
净利率HLMNRPRX
| Q1 26 | -1.3% | — | ||
| Q4 25 | 0.4% | 34.4% | ||
| Q3 25 | 5.5% | 47.3% | ||
| Q2 25 | 3.9% | 5.2% | ||
| Q1 25 | -0.1% | 41.9% | ||
| Q4 24 | -0.3% | 35.1% | ||
| Q3 24 | 1.9% | 96.3% | ||
| Q2 24 | 3.3% | 19.0% |
每股收益（稀释后）HLMNRPRX
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.00 | $0.49 | ||
| Q3 25 | $0.12 | $0.67 | ||
| Q2 25 | $0.08 | $0.07 | ||
| Q1 25 | $0.00 | $0.55 | ||
| Q4 24 | $-0.00 | $0.46 | ||
| Q3 24 | $0.04 | $1.21 | ||
| Q2 24 | $0.06 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $27.7M | $618.7M |
| 总债务越低越好 | $714.1M | $9.0B |
| 股东权益账面价值 | $1.2B | $9.7B |
| 总资产 | $2.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.59× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HLMNRPRX
| Q1 26 | $27.7M | — | ||
| Q4 25 | $27.3M | $618.7M | ||
| Q3 25 | $37.7M | $938.9M | ||
| Q2 25 | $34.2M | $631.9M | ||
| Q1 25 | $36.3M | $1.1B | ||
| Q4 24 | $44.5M | $929.0M | ||
| Q3 24 | $59.8M | $950.1M | ||
| Q2 24 | $54.0M | $1.8B |
总债务HLMNRPRX
| Q1 26 | $714.1M | — | ||
| Q4 25 | $668.3M | $9.0B | ||
| Q3 25 | $683.2M | $8.9B | ||
| Q2 25 | $683.1M | $8.0B | ||
| Q1 25 | $713.5M | $7.6B | ||
| Q4 24 | $691.7M | $7.6B | ||
| Q3 24 | $730.7M | $7.6B | ||
| Q2 24 | $732.1M | $7.6B |
股东权益HLMNRPRX
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.2B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.2B | $9.8B | ||
| Q4 24 | $1.2B | $10.3B | ||
| Q3 24 | $1.2B | $10.3B | ||
| Q2 24 | $1.2B | $9.8B |
总资产HLMNRPRX
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $19.6B | ||
| Q3 25 | $2.4B | $19.3B | ||
| Q2 25 | $2.4B | $18.3B | ||
| Q1 25 | $2.3B | $17.6B | ||
| Q4 24 | $2.3B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.4B | $17.7B |
负债/权益比HLMNRPRX
| Q1 26 | 0.59× | — | ||
| Q4 25 | 0.54× | 0.92× | ||
| Q3 25 | 0.56× | 0.93× | ||
| Q2 25 | 0.57× | 0.84× | ||
| Q1 25 | 0.60× | 0.78× | ||
| Q4 24 | 0.59× | 0.74× | ||
| Q3 24 | 0.62× | 0.74× | ||
| Q2 24 | 0.62× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-34.3M | — |
| 自由现金流率自由现金流/营收 | -9.3% | — |
| 资本支出强度资本支出/营收 | 4.0% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $22.1M | — |
8季度趋势，按日历期对齐
经营现金流HLMNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $30.9M | $827.1M | ||
| Q3 25 | $26.2M | $702.6M | ||
| Q2 25 | $48.7M | $364.0M | ||
| Q1 25 | $-655.0K | $596.1M | ||
| Q4 24 | $43.1M | $742.5M | ||
| Q3 24 | $63.7M | $703.6M | ||
| Q2 24 | $64.8M | $658.2M |
自由现金流HLMNRPRX
| Q1 26 | $-34.3M | — | ||
| Q4 25 | $16.1M | — | ||
| Q3 25 | $9.1M | — | ||
| Q2 25 | $31.2M | — | ||
| Q1 25 | $-21.3M | — | ||
| Q4 24 | $22.1M | — | ||
| Q3 24 | $39.6M | — | ||
| Q2 24 | $42.5M | — |
自由现金流率HLMNRPRX
| Q1 26 | -9.3% | — | ||
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | -5.9% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 10.1% | — | ||
| Q2 24 | 11.2% | — |
资本支出强度HLMNRPRX
| Q1 26 | 4.0% | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 6.1% | — | ||
| Q2 24 | 5.9% | — |
现金转化率HLMNRPRX
| Q1 26 | — | — | ||
| Q4 25 | 19.33× | 3.86× | ||
| Q3 25 | 1.13× | 2.44× | ||
| Q2 25 | 3.08× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 8.57× | 1.29× | ||
| Q2 24 | 5.17× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HLMN
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
